A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104
Condition(s):Neoplasms MalignantLast Updated:January 9, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Neoplasms MalignantLast Updated:January 9, 2023Completed
Condition(s):Hepatocellular Carcinoma; Adjuvant TherapyLast Updated:January 5, 2022Recruiting
Condition(s):Urothelial Carcinoma BladderLast Updated:March 3, 2022Recruiting
Condition(s):Cancer; Tumor, Solid; Malignant Neoplasm; Metastatic Cancer; Advanced Solid Tumor; Platinum-resistant Ovarian Cancer; Cutaneous Squamous Cell CarcinomaLast Updated:November 2, 2023Recruiting
Condition(s):Metastatic Breast CancerLast Updated:June 22, 2023Active, not recruiting
Condition(s):Advanced Colorectal CancerLast Updated:June 18, 2021Completed
Condition(s):Solid Tumors; Peritoneal CarcinomatosisLast Updated:March 6, 2024Recruiting
Condition(s):Non Small Cell Lung Cancer; Renal Cell CarcinomaLast Updated:November 17, 2020Withdrawn
Condition(s):Advanced Solid TumorLast Updated:March 27, 2024Not yet recruiting
Condition(s):Pancreatic Ductal Adenocarcinoma; Non-small Cell Lung Cancer; Squamous Cell Carcinoma of Head and NeckLast Updated:November 17, 2020Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.